NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

You can opt out at anytime by visiting our cookie policy page. In line with the provisions of the GDPR, the provision of your personal data is a requirement necessary to enter into a contract. We must advise you at the point of collecting your personal data that it is a required field, and the consequences of not providing the personal data is that we cannot provide this service to you.

Don't have an account? Subscribe

Lack of private prescription data raised

By Catherine Reilly - 07th Jan 2022

Closeup of pharmacist's hands taking medicines from shelf at the pharmacy

Lack of visibility of the private prescription of controlled drugs has been raised at a Medical Council stakeholder
group on overprescribing. Minutes of the group’s meetings, obtained by the Medical Independent (MI) under Freedom of Information law, also reported “concern that Ireland could go down the same route as the US regarding opioid addiction”.

The stakeholder group includes representatives from the Council, HSE, Department of Health, Pharmaceutical Society of Ireland, Health Products Regulatory Authority, ICGP, and College of Psychiatrists of Ireland. At a meeting of the group in March 2021, “the point was made that it can be difficult to get a full view on the prescribing of controlled drugs as currently private prescribing is not captured centrally….”

“There was a discussion with the representative from the Department of Health who said that she was aware that this topic had been discussed for some time and from the Department’s perspective, if legislative change is being suggested then the Department needs to know that all of the different pros and cons of a proposal have been considered.”

According to minutes, it was emphasised “that the legislative changes are required as the current situation just doesn’t make sense and that patient safety is at stake if this change doesn’t happen. It was acknowledged that the change does need to happen, but how it is done will need to be agreed.” A Department of Health spokesperson told MI: “The Department is participating in the working group with other stakeholders and is not in a position to comment further.”

Leave a Reply

Latest Issue
The Medical Independent 16th May 2023
The Medical Independent 16th May 2023

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read